Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cerise Yuen-Ki Chan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|June 16, 2019
Hypoxia and the Metastatic NicheCerise Yuen-Ki Chan, Vincent Wai-Hin Yuen, Carmen Chak-Lui Wong
Cancer Biology & Medicine|December 16, 2025
Harnessing the STING pathway for HCC treatmentCarmen Chak-Lui Wong, Cerise Yuen-Ki Chan, Helen Do-Gai Xue, et al.
JCI Insight|October 10, 2024
Cell cycle inhibitors activate the hypoxia-induced DDX41/STING pathway to mediate antitumor immune response in liver cancerPo Yee Wong, Cerise Yuen Ki Chan, Helen Do Gai Xue, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 30, 2022
Genome-Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer TreatmentChunxue Yang, Derek Lee, Misty Shuo Zhang, et al.
Hepatology (Baltimore, Md.)|December 5, 2023
Inhibition of CAF-1 histone chaperone complex triggers cytosolic DNA and dsRNA sensing pathways and induces intrinsic immunity of hepatocellular carcinomaFor-Fan Chan, Vincent Wai-Hin Yuen, Jialing Shen, et al.
Hepatology (Baltimore, Md.)|December 6, 2018
HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular CarcinomaCheuk-Ting Law, Lai Wei, Felice Ho-Ching Tsang, et al.
The Journal of Clinical Investigation|April 11, 2017
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinomaDerek Lee, Iris Ming-Jing Xu, David Kung-Chun Chiu, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 9, 2023
Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver CancerJacinth Wing-Sum Cheu, Derek Lee, Qidong Li, et al.
Journal of Hepatology|July 13, 2025
Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modificationYiling Chen, Derek Lee, Kenneth Kin-Leung Kwan, et al.
Oncogenesis|May 26, 2018
Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancerAki Pui-Wah Tse, Karen Man-Fong Sze, Queenie Tsung-Kwan Shea, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|June 16, 2019
Hypoxia and the Metastatic NicheCerise Yuen-Ki Chan, Vincent Wai-Hin Yuen, Carmen Chak-Lui Wong
Cancer Biology & Medicine|December 16, 2025
Harnessing the STING pathway for HCC treatmentCarmen Chak-Lui Wong, Cerise Yuen-Ki Chan, Helen Do-Gai Xue, et al.
JCI Insight|October 10, 2024
Cell cycle inhibitors activate the hypoxia-induced DDX41/STING pathway to mediate antitumor immune response in liver cancerPo Yee Wong, Cerise Yuen Ki Chan, Helen Do Gai Xue, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 30, 2022
Genome-Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer TreatmentChunxue Yang, Derek Lee, Misty Shuo Zhang, et al.
Hepatology (Baltimore, Md.)|December 5, 2023
Inhibition of CAF-1 histone chaperone complex triggers cytosolic DNA and dsRNA sensing pathways and induces intrinsic immunity of hepatocellular carcinomaFor-Fan Chan, Vincent Wai-Hin Yuen, Jialing Shen, et al.
Hepatology (Baltimore, Md.)|December 6, 2018
HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular CarcinomaCheuk-Ting Law, Lai Wei, Felice Ho-Ching Tsang, et al.
The Journal of Clinical Investigation|April 11, 2017
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinomaDerek Lee, Iris Ming-Jing Xu, David Kung-Chun Chiu, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 9, 2023
Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver CancerJacinth Wing-Sum Cheu, Derek Lee, Qidong Li, et al.
Journal of Hepatology|July 13, 2025
Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modificationYiling Chen, Derek Lee, Kenneth Kin-Leung Kwan, et al.
Oncogenesis|May 26, 2018
Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancerAki Pui-Wah Tse, Karen Man-Fong Sze, Queenie Tsung-Kwan Shea, et al.
Pageof 2